Investors should watch Asian vaccination rates for a guide to the continent's economic rebound.
Organon's management team has deep leadership, operating and financial experience.
Is HOOD walking into the public spotlight with a bulls-eye on its back before it gets a chance to prove itself?
Their earnings were a blowout but it's too dangerous to short the name.
There just isn't much downside left in most of the small-caps that have already been hit hard.
After being burned by Beijing, many U.S. investors are rightfully left wondering about their China-linked holdings.
Are traders and investors confused? Possibly. Was that the intent? No, but I think Jerome Powell is fine with that.
Here's what investors need to know to discern the direction of stocks during what can be a confusing season.
Senior indices and many big-caps are technically extended and prone to 'sell the news' reactions.
In a year full of boom and bust commodity moves, let's spill the beans on coffee's unruly rally.